Publication: Simple, efficient, and cost-effective multiplex genotyping with matrix assisted laser desorption/ionization time-of-flight mass spectrometry of hemoglobin beta gene mutations
Issued Date
2009-01-01
Resource Type
ISSN
15251578
Other identifier(s)
2-s2.0-69249138783
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Molecular Diagnostics. Vol.11, No.4 (2009), 334-346
Suggested Citation
Wanna Thongnoppakhun, Surasak Jiemsup, Suganya Yongkiettrakul, Chompunut Kanjanakorn, Chanin Limwongse, Prapon Wilairat, Anusorn Vanasant, Nanyawan Rungroj, Pa Thai Yenchitsomanus Simple, efficient, and cost-effective multiplex genotyping with matrix assisted laser desorption/ionization time-of-flight mass spectrometry of hemoglobin beta gene mutations. Journal of Molecular Diagnostics. Vol.11, No.4 (2009), 334-346. doi:10.2353/jmoldx.2009.080151 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/27326
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Simple, efficient, and cost-effective multiplex genotyping with matrix assisted laser desorption/ionization time-of-flight mass spectrometry of hemoglobin beta gene mutations
Other Contributor(s)
Abstract
A number of common mutations in the hemoglobin β (HBB) gene cause β-thalassemia, a monogenic disease with high prevalence in certain ethnic groups. As there are 30 HBB variants that cover more than 99.5% of HBB mutant alleles in the Thai population, an efficient and cost-effective screening method is required. Three panels of multiplex primer extensions, followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry were developed. The first panel simultaneously detected 21 of the most common HBB mutations, while the second panel screened nine additional mutations, plus seven of the first panel for confirmation; the third panel was used to confirm three HBB mutations, yielding a 9-Da mass difference that could not be clearly distinguished by the previous two panels. The protocol was both standardized using 40 samples of known genotypes and subsequently validated in 162 blind samples with 27 different genotypes (including a normal control), comprising heterozygous, compound heterozygous, and homozygous β-thalassemia. Results were in complete agreement with those from the genotyping results , conducted using three different methods overall. The method developed here permitted the detection of mutations missed using a single genotyping procedure. The procedure should serve as the method of choice for HBB genotyping due to its accuracy, sensitivity, and cost-effectiveness, and can be applied to studies of other gene variants that are potential disease biomarkers. Copyright © American Society for Investigative Pathology and the Association for Molecular Pathology.